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Featured Application: This study analyzes the suitability of the WB-EMS as a method to improve
Hepatic Fat Content and Cardiometabolic Risk in Postmenopausal Women.
Abstract: This 10-week randomized controlled trial investigates the effects of two different training
modalities on hepatic fat content and cardiometabolic risk in sedentary postmenopausal women.
Besides, alterations in physical fitness, hepatic fat content, and cardiometabolic risk will be asso-
ciated with changes in those blood parameters that are usually modifiable by exercise training.
Postmenopausal women ( n = 32; ~61 years) were randomly assigned to one of the following treat-
ment groups; (1) based on international exercise recommendations (EX group; n = 16), (2) exercise
plus whole-body electromyostimulation (EX+EMS group; n = 16). Cardiometabolic risk score was
calculated based on the international diabetes federation’s clinical criteria. Hepatic fat content was
estimated using the fatty liver index. After the intervention, the cardiometabolic risk and the fatty
liver index decreased, showing a higher impact on EX + WB-EMS. Physical fitness was assessed
through aerobic and strength tests belonging to “Eurofit Testing Battery”. In all of them, significant
differences were observed (p < 0.001), though EX+ EMS experienced better improvements (p < 0.05).
In conclusion, a 10-week exercise training program, especially with WB-EMS, triggered improve-
ments in physical fitness and reduced cardiometabolic risk and hepatic fat content in sedentary
postmenopausal women.
Keywords: whole-body electromyostimulation; postmenopausal; hepatic fat content; cardiometabolic
risk
Trial Registration: ISRCTN15558857 last edited: 02/12/2019 (retrospectively registered)
1. Introduction
The strong link between physical activity and health is a widely studied issue in
the literature from diverse points of view. A huge amount of studies try to explain the
relationship between these two paradigms [1–3]. The benefit that physical activity has
on the different systems and organs of the human body, as well as the improvements
which it promotes in functional capacity, has been established [4,5]. Consequently, there
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is compelling evidence showing the healthy impact of regular physical activity on older
adults [1,6]. Unfortunately, despite a demonstrated inverse relationship between moderate
to vigorous physical activity and cardiovascular or functional diseases in older adults
existing (≥50 years), few of them meet the physical activity recommendations made by
the World Health Organization (i.e., 150 min of moderate-intensity aerobic activity, 75 min
of vigorous-intensity aerobic activity, or an equivalent combination of them in 10 min
bouts, and muscle-strengthening activities, involving major muscle groups. It should be
done on 2 or more days a week.) [7]. In fact, previous researches concluded that sedentary
behaviors, such as TV viewing, motorized transport, or leisure-time sitting, have been
shown to contribute to adverse health outcomes in older people, such as deteriorated
body composition [4], hypertension [5], impaired glucose metabolism [8], altered lipid
metabolism (i.e., raised plasma triglycerides, total cholesterol and low-density lipopro-
tein cholesterol (LDL), and reduced high-density lipoprotein cholesterol (HDL)) [9], low
cardiorespiratory fitness [10], and low physical fitness [11].
Moreover, many studies have been carried out analyzing the effectiveness of some
novel biomarkers to predict hepatic steatosis and monitor responses to therapies [12,13].
An extensive number of clinical techniques have been used for non-alcoholic fatty liver
disease (NAFLD) diagnosis, but most of them are time-consuming, often very expensive,
and unavailable in many laboratories [14,15]. Interestingly, the exercise-based diagnosis
has been used as an important management strategy in this cohort [16]. It has been shown
that fatty liver index (FLI) scores of 60 and above (>60) indicate NAFLD [17]. In addition,
some studies reported the effect of vigorous exercise training interventions in reducing
fatty liver [18,19].
It is well established that physical activity and exercise training improve cardiovas-
cular function. In men, data show that vascular function is better in life-long physically
active subjects [20]. In contrast to the relatively well-documented effect of exercise training
in men, there is a paucity of studies in the literature related to cardiovascular function in
women [21]. It has been shown that flow-mediated dilation is improved after a period of
exercise training in aged men, but not in age-matched postmenopausal women [22]. It
was found in another cross-sectional study that life-long trained postmenopausal women
express a similar vascular dysfunction as their sedentary counterparts [23].
Menopause is an inevitable milestone among middle-aged women. With women’s
increasing life expectancy, even in developing countries, one-third to one-half of a woman’s
lifetime can be spent being postmenopausal [24]. Therefore, the health issues of post-
menopausal women have become a growing concern in the health-care community be-
cause, as a consequence of their endocrine status, changes in body composition and car-
diometabolic syndrome have been reported [25,26]. Risk factors for cardiovascular disease
include smoking, physical inactivity, age, metabolic syndrome, and loss of estrogen [21,26].
Estrogen has been shown to have a protective effect on the cardiovascular system in women
and the risk for cardiovascular events increases markedly after the menopausal transition,
when substantial hormonal changes occur, including the loss of estrogen production. The
implementation of exercise training can be used as a safe prophylactic strategy to oppose
deteriorations in the cardiac system [27]. Nevertheless, results from studies with post-
menopausal women concerning the effect of physical activity on their physical fitness and
cardiovascular health are inconsistent. The results have shown a lack of effect of a physical
activity program on some occasions and beneficial effects on others [21,25].
High-intensity training has been positioned as an efficient alternative [28] to induce
improvements on cardiometabolic health [29,30] and muscular strength [31] simultane-
ously [32], offering potentially better results in older and less fit individuals [32]. Although
high-intensity training has been considered the most popular time-efficient exercise method-
ology, new training tendencies are emerging. Several sports centers and hospitals have
been recently using a new exercise technique called whole body electromyostimulation
(WB-EMS). It consists of the application of a rectangular, biphasic and symmetrical current
by using a suit in which electrodes are strategically placed. The direct electrical impulse
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produces muscle contraction by transcutaneous peripheral nerve stimulation [33]. Devices
generally allow the simultaneous activation of thighs, arms, buttocks, abdomen, chest,
lower back area, upper back area, wide back and with two auxiliary channels of free
choice, with a total electrode area of 2800 cm2 [34]. The suitability of using WB-EMS as
an intensity method to improve the physical condition of older women has been raised,
since it guarantees sufficient effort in those people unable or unwilling to do so on their
initiative [35].
A recent systematic review concluded that, at the present time, despite the exis-
tence of some studies focusing on the improvement of cardiovascular endurance [36]
and strength [35,37–41], as well as cardiometabolic risk [38,42,43], there is little evidence
regarding the effectiveness of training with WB-EMS [44]. Regarding this controversy, new
studies whose protocols adequately conform to the scientific methodology should be car-
ried out [11,45]. Besides, to the best of the authors’ knowledge, no previous studies focused
on the association between physical fitness, cardiometabolic risk and the detection of non-
alcoholic fatty liver disease on postmenopausal women. Thus, the purpose of this study
was to compare the influence of traditional training vs. training whole-body electromyos-
timulation on physical fitness, cardiometabolic risk and detection of non-alcoholic fatty
liver disease in sedentary menopausal women, in a 10-week WB-EMS training program.
2. Materials and Methods
2.1. Ethics Statement and Reporting Philosophy
This study is part of a large project called INDEST2016 and was conducted from
September to November 2018. Its protocol was approved by the Ethics Committee of the
Arnau of Vilanova University Hospital, Lléida (Spain) (CEIC-1701), and complies with
the latest revision of the Declaration of Helsinki. A full description of it is available at
ISRCTNresistry (ISRCTN15558857); last edited: 02 December 2019, and is also accessible
elsewhere [46]. Data related to physical fitness after 10 weeks of WB-EMS training (i.e.,
balance, strength, velocity, power, flexibility, agility, speed and resistance) have been pub-
lished elsewhere [11,47]. In the present manuscript, we included the comparisons between
pre to post 10 weeks focused on hepatic fat content and cardiometabolic risk. Written,
informed consent was obtained from all potential participants before their inclusion in the
project. The reporting has been done following the CONSORT guideline for standard items
in interventional trials [48].
2.2. Participants
The experimental procedure of the study corresponded to a two-arm randomized trial
with parallel groups. The randomization of the study sample was carried out by a random
number computer generator [49]. The participants were randomized into two different
groups. The first group conducted a voluntary exercise program with superimposed
WB-EMS (EX + WB-EMS, n = 16 and the 2nd group performed only voluntary exercise
training (EX, n = 16). The general study design consisted of fitness condition, body
composition analysis and biochemical variables, before and after a 10-week training period
(see Figure 1).
Thirty-four post-menopausal women living in Lleida (Spain) were recruited to volun-
tarily participate in this investigation. The recruitment period lasted from June to August
2018. Briefly, in a first step, they were contacted by a phone call to be informed about
the nature of the project. All of them were invited to attend an informational meeting,
where more details were given on the benefits and possible risks that their participation in
the project might entail. Those who showed interest in their participation were recruited,
according to the inclusion criteria. Inclusion criteria were as follows: (1) reported con-
traindications (i.e., total endoprosthesis, abdomen/groin hernia, epilepsy, and cardiac
arrhythmia) for WB-EMS intervention, (2) sedentary status according to the scales pro-
vided by the Eurobarometer [50], (3) postmenopausal status (detailed below in a separated
section). Participants were allocated and informed about their assigned arm by a phone call
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which was made by an external collaborator. They were also assured of their anonymity
and the reporting of their views in aggregate form to protect their identities.
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2.3. Menopause Status
Hormone assessments were performed from fasting serum samples taken between 8:00
and 1 :00 AM. Serum wa separated by centrifugation for 10 min at 2200× g. Systemic FSH
levels were immunoassayed using IMMULITE 2000 XPi (Siemens Healthcare Diagnostics,
Oxford, UK). P rticipants’ menopause status was determined based on self-re orted
menstrual cycle.
Applying the categorization of Kovanen et al. 2018 [51], subjects were postmeno ausal
if o menstrual ble ding during the pa t 6 months, and the following cut values were
pplied FSH >30 IU/L. Participants self-reported their he lth problems, gynecologic tatus,
and use of medications.
2.4. Interventions
Throughout th 10-week program, groups performed two training sessions each
week with two rest days between sessions. The EX + WB-EMS group and the EX trained
on differentiated days of the week so that one ignored the existence of the other. Both
groups performed the same program consisting of endurance tasks and resistance strength
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exercises, but the EX + WB-EMS group also had a superimposed WB-EMS implemented
during the training. The complete electrostimulation equipment, consisting of the suit
and the electrostimulator device, does not weigh more than 1.5 kg and does not entail any
limitation or discomfort for the movement of the body. Participants were asked not to
make physical efforts outside the training program.
The sessions lasted 40 min. Participants performed a 10 min warm-up by walking
on a treadmill at a moderate speed. Subsequently, participants performed the resistance
training protocol, which consisted of performing 3 multi-articular exercises involving
push and pull actions (squat, deadlift, and bench press), as Aragão-Santos et al. 2018 [52]
suggest as a recommended option in older people. The resistance training protocol lasted
10 min, divided into 2 blocks of 5 min. One block consisted of 10 sets of each exercise.
Sets were composed of 2 repetitions with 2 s of eccentric and 1 s of concentric phase (6 s
in total per set). The intensity of the resistance training was 40% of the one-repetition
maximum (1RM) obtained by an indirect measurement test [53]. Following the line of
Wirtz et al. 2015 [54], the absolute load was increased by 5% every two weeks to apply
the principle of progressive overload. After strength exercises, participants performed a
10 min cardiovascular work on a treadmill, at a constant individualized speed, obtained
from the talk test [55] (i.e., the highest speed they could walk while talking). The intensity
of cardiovascular training was increased by 5% every week. Finally, the participants
performed 10 min of stretching of the muscles of the whole body as a cooldown. At the
end of each session, a scale was presented [56] with a range of 6 (no exertion at all) to
20 (maximal exertion), in which the participants of both groups recorded their internal
training load perception. The assessment was always close to 15 (Hard).
The EX + WB-EMS group performed the resistance strength training with superim-
posed WB-EMS. A rectangular, bipolar compensated current of 6 s duration and 4 s rest
was applied with a Wiemspro® electrostimulator (Malaga, Spain). The decision to use the
Wiemspro® device in this study is based on its lightweight and short size, which makes
it portable. Due to this, it is possible to wear the device attached to the body. This char-
acteristic means that it does not impede or restrain the body’s movements. Since there is
evidence that a current frequency ≥ of 50 Hz is necessary to cause adaptations in strength
training [57], during the strength exercises, a frequency of 55 Hz was applied with a 60%
duty cycle (pulse width: leg and glute 350 µs, lumbar, rectus abdominis and latissimus
dorsi 300 µs, trapezius 250 µs, chest 200 µs, and arms 150 µs) 800 ms ascent ramp and
descent ramp 500 ms [58,59]. Taking into account the effectiveness of low frequencies
of electrostimulation on the aerobic capacity [60], during cardiovascular training on the
treadmill, the current applied was 7 Hz, with a duty cycle of 100%.
The fat modifies the transmission of the electrical stimuli into muscle [61]. Thus, the
current intensity had to be normalized in the WB-EMS training. Following a procedure
similar to that of Kemmler et al. 2010 [62], four levels of intensity perception of the electrical
current (IPC) were established on a scale from 1 to 10 to control the perceived intensity
produced by the application of the WB-EMS in the participants, being from 1 to 4 (mild),
from 4 to 6 (moderate), from 6 to 8 (intense), and from 8 to 10 (pain). Participants gave
constant information on the IPC during the session. In the first two weeks, training was
conducted at a “moderate” IPC level to promote familiarization and adaptation to the WB-
EMS. In the remaining 8 weeks of the intervention, the intensity increased to an “intense”
IPC level. When the same intensity level is maintained during a WB-EMS session, the IPC
decreases over time. Hence, the intensity of the current increased gradually within the
same session, without exceeding the level of IPC corresponding to that session.
Harms.: Adverse events including physical injuries were monitored by the instructors
of the intervention and the responsible staff of the assessments. No harm occurred in the
present study.
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2.5. Assessments
The assessments were carried out during the week before the training began (pre-test)
and the week after the end of the intervention (post-test) in the sports center Ekke, located
in Lleida (Spain). The data were recorded in a spreadsheet that was stored in an encrypted
USB memory by an external collaborator, to guarantee the privacy of the participants. A
blinded statistician had access to the final dataset of the study. He assessed the safety and
validity of the research data. Participants were asked not to take any stimulants before
assessment to avoid their influence on the results.
2.5.1. Body Composition
As secondary outcomes, the following parameters were measured: height, weight,
body mass index (BMI) and waist perimeter. Height was determined with an accuracy of
0.10 cm with a SECA stadiometer (SECA, Hamburg, Germany). Participants were standing
erect without shoes, with heels together and the head in the Frankfort horizontal plane.
Body mass index was obtained using the formula: body weight/height2. To assess the
perimeters, a measuring tape (CESCORF) was used [63].
All measurements were made in duplicate non-consecutively, and using the average
value as the final value. All women were measured at the same time of the day for
baseline and post-test, to avoid errors due to differences in hydration. All analyses were
performed by a level I anthropometric technician certified by the International Society for
the Advancement of Kineanthropometry (ISAK), as described in its Reference Manual [64].
2.5.2. Blood Pressure
Blood pressure was determined in the right arm after a 30 min rest in a supine position,
using an Omrom® HEM 705 CP automatic monitor (OMROM Health-Care Co., Kyoto,
Japan), following the recommendations of the European Heart Society [65]. A minimum of
three measurements were taken 1 min apart, and the mean value was calculated.
2.5.3. Blood Samples
Venous blood samples were taken in fasting conditions (i.e., ~10 h) from the antecu-
bital vein and collected in ethylenediamine tetra-acetic acid-containing tubes using the
Vacutainer SST system (Becton Dickinson, Plymouth, UK). All samples were centrifuged at
4000 rpm for 7 min at 4 ◦C, and aliquots of plasma were stored in −80 ◦C blood samples.
Plasma glucose, total cholesterol, HDL-C, LDL, triglycerides, alanine transaminase (ALT),
-glutamyl transferase (GGT), creatine kinase (CK) and creatinine were determined using an
AU5800 absorption spectrophotometer (Beckman Coulter, Brea, CA, USA).
2.5.4. Cardiometabolic Risk Score
The International Diabetes Federation (IDF) has proposed as clinical criteria waist
circumference, blood pressure, plasma glucose, HDL-C, and triglyceride concentrations, to
define cardiometabolic risk [66]. Sex-specific cardiometabolic risk scores were calculated
based on these criteria [67]. Each variable was standardized as follows: standardized
value = (value—mean)/standard deviation. The HDL-C standardized values were multi-
plied by—1 to represent increasing values as directly proportional to the risk score. The
final score was determined as the sum of the five standardized scores divided by 5. The car-
diometabolic risk score is a continuous variable with a mean of 0 and a standard deviation
of 1 by definition, with lower scores denoting a more favorable profile.
2.5.5. Fatty Liver Index
FLI is a validated surrogate marker of NAFLD [68]. This was calculated from the BMI,
waist circumference, triglycerides, and GGT using the following equation [69]:
FLI = (e0.953 × loge (triglycerides) + 0.139 × BMI + 0.718 × loge (GGT) + 0.053 ×
waist circumference − 15745)/(1 × 100.953 × loge (triglycerides) + 0.139 × BMI + 0.718
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× loge (GGT) + 0.053 × waist circumference − 15.745) × 100. If FLI < 30 no NAFLD;
FLI > 60 NAFLD; FLI between 30–60 undetermined.
2.5.6. Physical Fitness Measures
The evaluation of the physical fitness was carried out using the tests modified and
previously adapted from the “Senior Fitness Test Battery” and “Eurofit Testing Battery” [70].
2.6. Statistical Procedures
Data are presented in mean ± standard deviation (SD). The assumption of normality
was assessed by exploring the Q-Q plots and histogram of residuals. The homogeneity
assumption was checked using Levene’s test. The effectiveness of interventions was
assessed by a 2-way mixed ANOVA. Group intervention (“EX+WB-EMS”, “EX”) was
included as between-subject factor, time (“Pre”, “Post”) was included as the repeated
with-in subject factor, and group × time was included to account for the interaction effects.
Whenever a significant main effect or interaction was observed, Bonferroni’s post hoc
correction was used to aid interpretation. The statistician was blind to both groups during
data analyses. The significance level was set at α = 0.05 for all tests. All statistical analyses




The baseline characteristics of the study sample are shown in Table 1. Non-statistically
significant mean differences were shown between groups (p > 0.005).
Table 1. Summary of baseline characteristics of the sample.
Outcome All EX+WB-EMS EX p-Value
Age (years) 61.59 ± 3.95 62.94 ± 3.32 60.25 ± 4.17 0.053
Body mass (kg) 67.44 ± 10.84 67.11 ± 11.84 67.78 ± 10.12 0.866
Height (cm) 158.32 ± 5.28 156.69 ± 5.02 159.94 ± 5.18 0.081
Body mass index
(kg/m2) 26.91 ± 4.11 27.29 ± 4.25 26.54 ± 4.08 0.614
Data are presented as mean ± SD. WB-EMS: Whole body electromyostimulation. EX + WB-EMS: Voluntary
exercise with WB-EMS; EX: Voluntary exercise group.
3.2. Body Composition
The between-group changes in body composition outcomes are shown in Table 2.
Non-significant main effects of time and group per time interactions were shown in all
outcomes (p > 0.05).
Table 2. Summary of between-group changes in body composition outcomes.
Outcome Group Week 0 Week 10 MD [95% CI] p (Time) p (Group ×Time)
Weight (kg) All 67.44 ± 10.84 67.15 ± 11.04 0.29 [−0.27, 0.85] 0.295 0.991
EX + WB-EMS 67.11 ± 11.84 66.82 ± 12.10 0.29 [−0.80, 1,38]
EX 67.78 ± 10.12 67.49 ± 10.27 0.29 [−0.80, 1,38]
BMI (kg/m2) All 26.91 ± 4.11 26.81 ± 4.16 0.10 [−0.13, 0.34] 0.367 0.853
EX + WB-EMS 27.29 ± 4.25 27.16 ± 4.28 0.13 [−0.33, 0.58]
EX 26.54 ± 4.08 26.46 ± 4.15 0.08 [−0.37, 0.54]
Waist (cm) All 82.02 ± 16.99 83.86 ± 10.50 −1.83 [−6.85, 2.84] 0.428 0.283
EX + WB-EMS 84.13 ± 10.88 83.47 ± 10.11 0.66 [−8.48, 9.81]
EX 79.90 ± 21.64 84.24 ± 11.19 −4.34 [−13.48, 4.80]
Data are presented as mean ± SD. WB-EMS: Whole body electromyostimulation. EX+WB-EMS: exercise plus whole-body electrostimulation
group; EX: exercise only group; EX + WB-EMS: Voluntary exercise with WB-EMS group; EX: Voluntary exercise group. Abbreviations: EX:
exercise only group; MD: estimated mean difference; CI: confidence in-terval; p: p Value.
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3.3. Clinical Outcomes
The between-group changes on clinical outcomes are shown in Table 3. A significant
main effect of time was shown in systolic blood pressure (p = 0.028, η2p = 0.19, pre-post
MD = 6.88 mmHg 95% CI [0.80, 12.96]), diastolic blood pressure (p = 0.008, η2p = 0.26,
pre-post MD = 3.60 mmHg 95% CI [1.03, 6.17]), mean blood pressure (p = 0.002, η2p = 0.34,
pre-post MD = 4.69 mmHg 95% CI [1.95, 7.43]) and creatine kinase (p = 0.008, η2p = 0.21,
pre-post MD = 31.09 IU/L 95% CI [8.74, 53.45]). Despite non-statistically significant
interactions being shown in all clinical outcomes (p > 0.05), the EX + WB-EMS groups
obtained higher pre-post estimated mean differences in systolic blood pressure, ALT, GGT
and fatty liver index.
Table 3. Summary of between-group changes in clinical outcomes.







All 121.14 ± 16.80 127.00 ± 20.76 6.88 [0.80, 12.96] 0.028 0.516
EX + WB-EMS 122.64 ± 16.90 131.46 ± 21.88 8.82 [−4.05, 21.69]




All 73.32 ± 7.89 76.70 ± 7.29 3.60 [1.03, 6.17] 0.008 0.211
EX + WB-EMS 74.00 ± 7.94 76.00 ± 6.40 2.00 [−3.43, 7.43]




All 89.26 ± 9.61 93.47 ± 10.49 4.69 [1.95, 7.43] 0.002 0.755
EX + WB-EMS 90.21 ± 8.81 94.49 ± 9.94 4.27 [−1.53, 10.07]
EX 88.09 ± 10.89 93.20 ± 9.70 5.11 [0.14, 10.08]
Liver function
ALT (IU/L) All 24.72 ± 16.04 21.28 ± 13.39 −3.44 [−10.31, 3.43] 0.315 0.203
EX + WB-EMS 30.81 ± 20.35 23.00 ± 16.96 −7.81 [−21.25, 5.63]
EX 18.63 ± 6.17 19.56 ± 8.76 0.94 [−12.50, 14.38]
GGT (IU/L) All 26.91 ± 21.74 22.56 ± 13.04 −4.34 [−12.12, 3.43] 0.263 0.655
EX + WB-EMS 31.46 ± 28.80 25.50 ± 16.55 −6.06 [−21.26, 9.14]
EX 22.25 ± 10.04 19.63 ± 7.68 −2.63 [17.83, 12.58]
Fatty liver
index All 30.70 ± 27.67 28.16 ± 25.78 −2.55 [−6.79, 1.70] 0.230 0.381
EX + WB-EMS 34.05 ± 29.11 29.65 ± 26.54 −4.39 [−12.70, 3.91]




(CPK; IU/L) All 101.66 ± 39.33 132.75 ± 67.21 31.09 [8.74, 53.45] 0.008 0.182
EX + WB-EMS 94.19 ± 41.45 140.25 ± 81.71 46.06 [2.33, 89.79]
EX 109.13 ± 36.87 125.50 ± 48.72 16.13 [−27.61, 59.86]
Creatinine
(mg/dL) All 0.71 ± 0.10 0.70 ± 0.11 −0.00 [−0.03, 0.02] 0.812 0.812
EX + WB-EMS 0.71 ± 0.10 0.71 ± 0.12
EX 0.70 ± 0.10 0.70 ± 0.11
Data are presented as mean ± SD. WB-EMS: Whole body electromyostimulation. EX + WB-EMS: Voluntary exercise with WB-EMS;
EX: Voluntary exercise group. Significant mean differences and p-values (p ≤ 0.05) are shown in bold. Abbreviations: ALT—Alanine
transaminase; GGT—glutamyl transferase, EX: exercise only group; MD: mean difference; CI: confidence interval; p: p Value.
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3.4. Hematological Outcomes
The between-group changes in hematological measures are shown in Table 4. A
significant main effect of time was shown in glucose only (p = 0.015, η2p = 0.18, pre-
post MD = 4.19 mmol/L 95% CI [0.88, 7.50]). Even though non-statistically significant
interactions were shown in all clinical outcomes (p > 0.05), the EX + WB-EMS groups
obtained higher pre-post estimated mean differences in HDL, triglycerides, glucose and
cardiometabolic risk score.
Table 4. Summary of between-group changes on hematological measures.






All 222.88 ± 25.95 218.88 ± 31.10 −4.00 [−14.04, 6.04] 0.422 0.920
EX + WB-EMS 219.19 ± 29.90 215.69 ± 37.15 −3.50 [−23.14, 16.14]
EX 226.56 ± 21.65 222.06 ± 24.43 −4.50 [−24.14, 15.14]
HDL (mmol/L) All 64.78 ± 12.88 65.88 ± 14.08 1.09 [−2.16, 4.34] 0.497 0.547
EX + WB-EMS 66.19 ± 15.38 68.25 ± 15.64 2.06 [−4.29, 8.42]
EX 63.38 ± 10.10 63.50 ± 12.37 0.13 [−6.23, 6.48]
LDL (mmol/L) All 142.45 ± 32.64 135.67 ± 25.70 −6.78 [−18.05, 4.49] 0.229 0.624
EX + WB-EMS 134.20 ± 22.76 130.15 ± 28.67 −4.05 [−26.10, 18.00]
EX 150.70 ± 39.23 141.19 ± 21.88 −9.51 [−31.56, 12.54]
Triglycerids
(mmol/L) All 93.84 ± 35.21 86.97 ± 23.22 −6.88 [.18.28, 4.53] 0.228 0.903
EX + WB-EMS 94.00 ± 41.79 86.44 ± 22.22 −7.56 [−29.88, 14.75]
EX 93.69 ± 28.56 87.50 ± 24.91 −6.19 [−28.50, 16.13]
Glucose
(mmol/L) All 90.78 ± 10.52 94.97 ± 10.16 4.19 [0.88, 7.50] 0.015 0.848
EX + WB-EMS 91.38 ± 11.88 95.88 ± 8.39 4.50 [−1.97, 10.97]
EX 90.19 ± 9.30 94.06 ± 11.89 3.88 [−2.59, 10.34]
Cardiometabolic
risk score All −0.26 ± 0.88 −0.07 ± 0.52 0.19 [−0.13, 0.51] 0.235 0.574
EX + WB-EMS −0.42 ± 1.09 −0.14 ± 0.44 0.28 [−0.35, 0.91]
EX −0.10 ± 0.62 0.00 ± 0.59 0.10 [−0.53, 0.73]
Data are presented as mean ± SD. WB-EMS: Whole body electromyostimulation. EX + WB-EMS: Voluntary exercise with WB-EMS; EX:
Voluntary exercise group. Significant mean differences and p-values (p ≤ 0.05) are shown in bold. Abbreviations: HDL-high-density
lipoprotein cholesterol; LDL—low-density lipoprotein, EX: exercise only group; MD: mean difference; CI: confidence interval; p: p Value.
3.5. Physical Fitness Outcomes
The between-group changes on fitness measures are shown in Table 5. The data
revealed a significant main effect of time (p < 0.001, η2p = 0.81) and interaction (p = 0.025,
η2p = 0.18) in strength of right arm. Post-hoc tests revealed significant mean differ-
ence between the pre- and post-tests of both groups (EX+WB-EMS: 6.50 repetitions 95%
CI [4.41, 8.59], pBonferroni < 0.001; EX: 4.13 repetitions 95% CI [2.03, 6.22], pBonferroni < 0.001).
However, non-statistically significant between-group differences were shown in either pre-
test or post-test (pre-test: 1.44 repetitions 95% CI [−1.06, 3.93], pBonferroni = 0.723; post-test:
−0.93 repetitions 95% CI [−3.43, 1.56], pBonferroni = 1.000).
A significant main effect of time (p < 0.001, η2p = 0.84) and interaction (p = 0.031,
η2p = 0.17) was obtained in strength of left arm. Post-hoc tests revealed a significant mean
difference between pre and post-tests of both groups (EX+WB-EMS: 6.56 repetitions 95%
CI [4.81, 8.31], pBonferroni < 0.001; EX: 4.37 repetitions 95% CI [2.63, 6.12], pBonferroni < 0.001).
However, non-statistically significant between-group differences were shown in either pre-
test or post-test (pre-test: 1.43 repetitions 95% CI [−1.16, 4.03], pBonferroni = 0.800; post-test:
−0.75 repetitions 95% CI [−3.34, 1.84], pBonferroni = 1.000).
Finally, a significant main effect of time (p < 0.001, η2p = 0.81) and interaction (p > 0.001,
η2p = 0.68) was obtained in the 6 min walk test. Post hoc tests revealed significant
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mean differences between pre- and post-tests of EX+WB-EMS group (155.54 m 95% CI
[122.99, 188.08], pBonferroni < 0.001), but not in the EX group (25.66 m 95% CI [−6.88, 58.21],
emphpBonferroni = 0.201). Statistically significant between-group differences were shown in
post-test (−117.63 m 95% CI [−174.54, 60.71], pBonferroni < 0.001), but not in pre-test (12.25 m
95% CI [−44.66, 69.16], pBonferroni = 1.0000).
Table 5. Summary of between-group changes on physical fitness measures.




arm (reps) All 15.53 ± 2.57 20.84 ± 2.65 5.31 [4.24, 6.38] <0.001 0.031
EX + WB-EMS 14.81 ± 2.26 21.31 ± 3.05 6.50 [4.41, 8.59]
EX 16.25 ± 2.72 20.375 ± 2.19 4.13 [2.03, 6.22]
Strength left
arm (reps) All 15.78 ± 2.46 21.25 ± 2.89 5.47 [4.58, 6.36] <0.001 0.018
EX + WB-EMS 15.06 ± 1.73 21.63 ± 3.074 6.56 [4.82, 8.31]
EX 16.50 ± 2.90 20.88 ± 2.73 4.38 [2.63, 6.12]
6 min walk
test (m) All 567.90 ± 57.32 658.50 ± 82.74 90.60 [73.96, 107.24] <0.001 <0.001
EX + WB-EMS 561.78 ± 54.58 717.31 ± 59.91 # 155.54 [122.99, 188.08]
EX 574.03 ± 61.09 599.688 ± 56.41 25.66 [−6.88, 58.21]
Data are presented as mean ± SD. WB-EMS: Whole body electromyostimulation. EX + WB-EMS: Voluntary exercise with WB-EMS; EX:
Voluntary exercise group. Significant mean differences and p-values (p ≤ 0.05) are shown in bold. # pBonferroni ≤ 0.05 different to EX group
values. EX: exercise only group; MD: mean difference; CI: confidence interval, p: p Value.
4. Discussion
The main finding of this work is that a 10-week supervised exercise intervention pro-
duces effects in cardiometabolic risk, NAFLD parameters and physical fitness in sedentary
postmenopausal women. It should be noted that, although EX and EX + WB-EMS experi-
enced reductions in their cardiometabolic risk, a slightly higher effect in EX + WB-EMS can
be observed. Besides, despite the exigent exercitation in this study, the CK values indicated
the inexistence of rhabdomyolysis.
Body composition and distribution of the fat tissue experience changes over the
years [71]. Mainly, the menopause stage favors fat accumulation. Thus, menopausal women
often gain around 10% of their pre-menopause weight [72,73]. Following the line of the
present study, some other research groups have found a prevalence of 80% of overweight
and obesity in Spanish postmenopausal women [74–76]. Therefore, the determination
of body composition is an important factor that should not be disregarded. The study
of this variable may help in the improvement of medical knowledge in postmenopausal
sedentary women. Waist circumference is a predictor of visceral fat located in the abdominal
region [77]. Its measurement is an easy and low-cost procedure with relevant importance
in population-based studies [78]. Waist circumference shows a high correlation with the
majority of metabolic risk factors [78,79]. Some previous studies assessed the effects of
WB-EMS on body composition of untrained old adult men and women finding statistical
differences, but showing a high risk of bias because of the different and not comparable
treatments applied to the study groups [38,43,62,80–84]. It impairs their data reliability.
In the present study, EX + WB-EMS group did not show significant differences in waist
circumference, weight, or IMC compared to the EX group as it happens in other studies
where the body composition does not show differences [36,41,85,86].
Many authors have studied the effect of moderate and intense intensity physical
activity on blood pressure, obtaining results similar to ours [87]. Arterial hypertension is
a chronic or persistent increase in systolic blood pressure (SBP) greater than or equal to
140 mmHg and/or a diastolic blood pressure (DBP) greater than 90 mmHg1. In our work,
it is appreciated how these values are not exceeded. Perhaps in future work, it will be
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necessary to propose more extended aerobic tasks in order to obtain a significant drop in
blood pressure, as stated by different authors [88,89].
Recently, WB-EMS is an effective tool for improving muscle strength outcome mea-
surements in deconditioned subjects [11]. However, an excessive intensity in the first phase
of a WB-EMS training program was related to some severe side effects. A few case reports
have characterized substantial muscle damage and rhabdomyolysis following just one
single training session [90–92]. In fact, recent studies showed an extreme increase in muscle
damage markers, such as CK after a WB-EMS application [93,94]. In the present study, the
results showed values considered normal in the literature [95]. An increase of CK values
begins between 2 and 12 h after the muscular damage and then a progressive decrease is
observed during the next five days if the exercise stops [96]. Muscular damage is usually
accompanied by an increase of GGT and ALT, which could emulate hepatic damage [97].
In the present study, the GGT and ALT decreased, which could confirm, together with
the CK values, that no subject of this study suffered rhabdomyolysis. As indicated by the
literature, the correct application of the training program by professionals is important for
safe and effective training [91,93]. In this study, the training protocols were supervised by
two instructors graduated in Physical Activity and Sports Sciences and post-graduated
in Sports Training. Their academic formation and wide experience in WB-EMS training
guaranteed the correct training load administration, which led to safety training with a
decreasing GGT and ALT.
We observed changes in triglycerides in both groups, which is in agreement with the
results of previous studies showing a positive influence of concurrent training in the blood
triglyceride values [98,99]. This could be explained by the idea that combined strength
and aerobic training increases the rate of fat oxidation, also presenting triglycerides as
an important source of fuel for this type of exercise. Exercise would lead to triglycerides
consumed by muscle tissue, and increases lipoprotein lipase (LPL), which would result in
more triglycerides hydrolysis [100].
Recent studies have shown that low skeletal muscle mass can contribute to NAFLD,
mostly in postmenopausal women [101,102]. The FLI was described by Bedogni et al.,
2006 [68] for the diagnosis of patients with NAFLD, and includes BMI, abdominal cir-
cumference, triglycerides and GGT, with values ranging from 0 to 100. NAFLD, which is
associated with cardiovascular disease, is characterized by the deposition of free fatty acids
and triglycerides in the cytoplasm of hepatocytes, in the form of large vacuoles, in patients
without toxic alcohol consumption, and not associated with other liver diseases [103,104].
It is also a predictor of type 2 diabetes [105]. Thus, the role of FLI as an independent marker
of cardiovascular disease, without cardiovascular risk factors, is interesting. According
to the results of three studies, when FLI value is higher than 60, it indicates an increased
cardiovascular risk [106,107]. In our work, we found that FLI improved significantly after
10 weeks of training in both groups. The whole sample ended up with FLI below 30, which
is the value recommended by scientific societies as a predictor of good health [108]. It
should be noted that, in the case of the EX + WB-EMS group, the effect size was much
larger than in the EX group. The improvement of some subject’s FLI in this study may
reflect the reduction of ectopic fat deposits that are responsible for the improvement of
insulin resistance, these results would confirm those found by other authors [106]. Some
studies suggested positive effects of an exercise intervention on liver metabolic signaling
pathways, such as improved oxidative enzyme activity, increased fatty acid oxidation and
reduced intracellular lipid accumulation in the liver [109]. Barsalani et al. 2013 illustrated
that significant changes can be observed in FLI response following lifestyle intervention
such as exercise training and diets [110]. It has been established that the improvement of
the FLI is linked to the intensity of the exercise [111]. The valuable information provided
by our study is that the EX + WB-EMS group showed remarkably better improvement
compared to the EX group, so we suspect that WB-EMS training could be an adequate
exercise methodology for the treatment of high FLI.
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It has been reported that exercise training can lead to cardiometabolic benefits, such
as reductions in waist circumference, LDL, triglycerides and blood pressure, as well as
an increase in HDL [98,112]. In the present study, we observed an increment of HDL and
glucose. The LDL and triglycerides decreased and blood pressure slightly increased in both
groups. The low level of HDL cholesterol is a powerful predictor of the increased cardio-
vascular risk factor [113]. It must be pointed out that, although the EX and EX + WB-EMS
groups experienced reductions in cardiometabolic risk, the improvement observed in the
EX + WB-EMS group is clinically greater. According to previous studies, HDL levels
are significantly higher in premenopausal and postmenopausal women compared with
age-matched men [73]. Therefore, this could be considered as a gender-specific protective
factor [114]. Our results show that, while a physical exercise intervention based on the
international recommendations (EX group) improved the cardiometabolic score values,
EX + WB-EMS improved slightly more, so it can be suggested that the same exercise train-
ing with simultaneous WB-EMS could be a suitable complement to enhance those effects.
Thus, the present study follows the same line as Schink et al. 2018 [115], who conclude
that WB-EMS can be used as a complement to voluntary exercise, for improving fitness
and health in healthy subjects and in patients who cannot perform conventional voluntary
exercise because of illness.
The glucose levels in this study’s baseline would be in concordance with those ob-
tained in previous studies, both in other Spanish regions and other developed coun-
tries [116–118]. This pattern is repeated in most European countries, according to studies by
the World Health Organization [119,120]. The glucose values never exceeded <100 mg/dL,
which is considered to be under healthy parameters [120]. The data indicated that the two
groups presented slightly higher levels of glucose than the basal ones, against what could
be expected. It could be attributed to a greater hepatic and muscular glycogen capacity of
mobilization, which would lead to a better performance in physical activities [118].
Aging, together with usually low estrogen levels, is commonly related to decreases
in postmenopausal women’s muscle function [121]. This phenomenon is greatly related
to impairments in muscle strength [122,123]. The decline in strength in older adults has
been linked to impaired ability to perform daily living tasks, including climbing stairs
and rising from a chair, together with reduced ability to recover from a trip or a slip [2].
Therefore, strength maintenance is important in fall prevention and independence. Due to
this, methodologies that aim the strength enhancement are of extraordinary importance in
the postmenopausal woman.
On one hand, throughout the last years, some studies observed successful results in
the use of WB-EMS to enhance maximum dynamic and isometric strength in older individ-
uals [35,39,62,124,125]. Unfortunately, the corresponding protocols could not guarantee
the reliability of the extracted data, showing a high risk of bias [44]. On the hand, Amaro
et al. 2019 [45] carried out a 12-week randomized controlled trial with a parallel group, in
which one of the groups performed a high-intensity interval training (HIIT group). In the
same way as our protocol, their experimental group performed the same training program
adding WB-EMS. The authors did not observe significant differences. Taking into account
the obvious controversy, as well as the lack of bibliography analyzing the WB-EMS’s effects
on the strength in the older adults, there is a need for future clinical trials aimed at resolving
the problem.
Many of the studies that try to associate physical condition with lifestyle have shown
that the level of activity positively influences the strength of the legs, arms and aerobic
capacity [126,127]. Indeed, strength and aerobic capacity are the two components with a
more important influence on people’s health and functional independence [112]. There
is a quality of evidence related to the implication of strength in the level of autonomy
and independence of people [128,129]. In detail, lower limb strength has been linked to
a better subjective perception of functional status [130]. In the present study, we have
found significant improvements in both groups in both leg and arm strength and aerobic
resistance. Besides, significant improvements have been observed between groups in
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favor of the EX + WB-EMS group. For this reason, we suggest that a 10-week combined
exercise program of strength and resistance with WB-EMS leads to higher improvements
than traditional training in postmenopausal women. When women enter the menopause
phase, estrogen production decrease and the many beneficial effects of this hormone on
cardiovascular health are lost whereby the age-related risk of cardiovascular disease is
accelerated [21]. Hormone replacement therapy can, to some extent, counteract the loss of
estrogen, but an attractive alternative to hormone therapy is regular physical activity, as it
is known that exercise induces many of the same cardiovascular health protective effects as
estrogen [21].
The training done in this job seems to be relatively safe. As a result, the prevention
of functional deterioration is obtained, which allows a greater capacity to carry out the
activities of daily life. It is important to note that no side effects have been reported
associated with WB-EMS training. Even though physical performance decreases with
aging, the activities carried out in this training program seem to be useful to guarantee
higher levels of strength and endurance in postmenopausal women.
The study’s findings indicated that there was an association between cardiac risk,
FLI, and physical fitness in postmenopausal women, suggesting that physical fitness is
associated with better cardiovascular and functional health. However, despite scientific
evidence, it should be borne in mind that this training methodology is not accessible to the
general population. Knowing the strong association between physical fitness and health
parameters, the practice of this type of activity should be promoted by public institutions to
specific populations such as postmenopausal women, to improve their health and increase
their functional capacity.
The present study has several strengths. Although there is no current established
gold standard to determine physical fitness in older adults, the proposed tets have been
positioned as one of the most used tools to objectively evaluate functional performance
among older adults. Similarly, the fatty liver index and cardiometabolic risk score have
been suggested as a more sensitive scale for detecting changes in the individual’s biological
status than previously validated instruments. As another strength of this study, we should
mention that its protocol ensures the assessment of the isolated WB-EMS’ effects, since
both groups performed the same training program in the intervention.
Our study also has limitations. The nutritional control of the sample was not carried
out throughout the treatment, since only instructions regarding keeping on with the usual
diet were given to participants. The importance of caloric intake control is necessary for
the aiming of body composition and cardiovascular improvements. Finally, in order to
estimate the maximum intensity at which the participants could be electrostimulated,
a pain threshold test was performed. This could be a parameter that has an excessive
subjectivity, so we cannot categorically state that the intensity at which the current was
applied was that required to cause adaptations.
5. Conclusions
The use of this new training technique has interesting results. The finding of this work
suggests that a supervised exercise training intervention (independently of its modality)
improves cardiometabolic risk, physical fitness, and fatty liver index in postmenopausal
women. Although both groups experienced reductions in cardiometabolic risk, the effect
seen in the EX+EMS group could be clinically greater. It should be pointed out that
the creatine kinase in the EX + EMS group did not exceed the limits considered normal,
indicating the absence of excessive muscle damage. These findings suggest that if the
technology is used correctly, the results are positive. Further research is needed to consider
the impact of WB-EMS on postmenopausal women.
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